Evaluating the use of PCR for diagnosing invasive aspergillosis

Introduction: Aspergillus species, primarily Aspergillus fumigatus, are still the most emerging fungal pathogens. Within recent years, novel molecular methods have been developed to improve the diagnosis of life-threatening invasive aspergillosis in high risk patients. Especially patients with malig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Buchheidt, Dieter (VerfasserIn) , Reinwald, Mark (VerfasserIn) , Hofmann, Wolf-Karsten (VerfasserIn) , Boch, Tobias (VerfasserIn) , Spiess, Birgit (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 10 May 2017
In: Expert review of molecular diagnostics
Year: 2017, Jahrgang: 17, Heft: 6, Pages: 603-610
ISSN:1744-8352
DOI:10.1080/14737159.2017.1325735
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1080/14737159.2017.1325735
Verlag, Volltext: https://doi.org/10.1080/14737159.2017.1325735
Volltext
Verfasserangaben:Dieter Buchheidt, Mark Reinwald, Wolf-Karsten Hofmann, Tobias Boch, Birgit Spiess

MARC

LEADER 00000caa a2200000 c 4500
001 1571694617
003 DE-627
005 20230426124230.0
007 cr uuu---uuuuu
008 180404s2017 xx |||||o 00| ||eng c
024 7 |a 10.1080/14737159.2017.1325735  |2 doi 
035 |a (DE-627)1571694617 
035 |a (DE-576)501694617 
035 |a (DE-599)BSZ501694617 
035 |a (OCoLC)1341001054 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Buchheidt, Dieter  |d 1955-  |e VerfasserIn  |0 (DE-588)1028287461  |0 (DE-627)730538621  |0 (DE-576)375787380  |4 aut 
245 1 0 |a Evaluating the use of PCR for diagnosing invasive aspergillosis  |c Dieter Buchheidt, Mark Reinwald, Wolf-Karsten Hofmann, Tobias Boch, Birgit Spiess 
264 1 |c 10 May 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.04.2018 
520 |a Introduction: Aspergillus species, primarily Aspergillus fumigatus, are still the most emerging fungal pathogens. Within recent years, novel molecular methods have been developed to improve the diagnosis of life-threatening invasive aspergillosis in high risk patients. Especially patients with malignant hematological diseases undergoing intensive chemotherapy are at risk and mortality rates are exceptionally high, in part due to difficulties and delays in establishing a microbiologic diagnosis. Early diagnosis and treatment are crucial for an adequate therapeutical management, but, however, are hardly achieved in the clinical setting because most of the current conventional diagnostic tools either lack specificity or acceptable sensitivity at the critical early phase of the infection.Areas covered: To review the clinical value, advantages and problems as well as drawbacks of molecular approaches, especially polymerase chain reaction (PCR)-based assays to detect genomic DNA of Aspergillus species in clinical samples of immunocompromised, especially hematological patients at high risk for IA, a comprehensive review of the literature was performed and expert opinion was expressed.Expert commentary: The results of numerous attempts to diagnose invasive aspergillosis by PCR-based detection of fungal genome in clinical samples highlight the potential of the PCR technique to improve early diagnosis of invasive aspergillosis in patients with hematological malignancies during intensive antineoplastic treatment, combined with imaging surveillance and serologic diagnostic tools. Further comparative validation of reliable assays in prospective multicenter studies is mandatory and urgently needed in order to establish a harmonization and standardization, so that ‘gold standard assays’ may be incorporated into diagnostic and therapeutic algorithms that improve the prognosis of patients with life-threatening infections caused by Aspergillus species. 
650 4 |a Aspergillus species 
650 4 |a diagnosis 
650 4 |a hematology 
650 4 |a invasive pulmonary aspergillosis 
650 4 |a PCR assays 
700 1 |a Reinwald, Mark  |d 1975-  |e VerfasserIn  |0 (DE-588)131809083  |0 (DE-627)514269928  |0 (DE-576)298766515  |4 aut 
700 1 |a Hofmann, Wolf-Karsten  |d 1967-  |e VerfasserIn  |0 (DE-588)114154635  |0 (DE-627)691208751  |0 (DE-576)351568336  |4 aut 
700 1 |a Boch, Tobias  |d 1984-  |e VerfasserIn  |0 (DE-588)1052922015  |0 (DE-627)789313847  |0 (DE-576)40866732X  |4 aut 
700 1 |a Spiess, Birgit  |d 1972-  |e VerfasserIn  |0 (DE-588)1028287496  |0 (DE-627)730538699  |0 (DE-576)37578764X  |4 aut 
773 0 8 |i Enthalten in  |t Expert review of molecular diagnostics  |d Abingdon : Taylor & Francis Group, 2001  |g 17(2017), 6, Seite 603-610  |h Online-Ressource  |w (DE-627)355690462  |w (DE-600)2090852-0  |w (DE-576)36671337X  |x 1744-8352  |7 nnas  |a Evaluating the use of PCR for diagnosing invasive aspergillosis 
773 1 8 |g volume:17  |g year:2017  |g number:6  |g pages:603-610  |g extent:8  |a Evaluating the use of PCR for diagnosing invasive aspergillosis 
856 4 0 |u http://dx.doi.org/10.1080/14737159.2017.1325735  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1080/14737159.2017.1325735  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180404 
993 |a Article 
994 |a 2017 
998 |g 1028287496  |a Spiess, Birgit  |m 1028287496:Spiess, Birgit  |d 60000  |d 61200  |e 60000PS1028287496  |e 61200PS1028287496  |k 0/60000/  |k 1/60000/61200/  |p 5  |y j 
998 |g 1052922015  |a Boch, Tobias  |m 1052922015:Boch, Tobias  |d 60000  |d 61200  |e 60000PB1052922015  |e 61200PB1052922015  |k 0/60000/  |k 1/60000/61200/  |p 4 
998 |g 114154635  |a Hofmann, Wolf-Karsten  |m 114154635:Hofmann, Wolf-Karsten  |d 60000  |d 61200  |e 60000PH114154635  |e 61200PH114154635  |k 0/60000/  |k 1/60000/61200/  |p 3 
998 |g 131809083  |a Reinwald, Mark  |m 131809083:Reinwald, Mark  |d 60000  |d 61200  |e 60000PR131809083  |e 61200PR131809083  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 1028287461  |a Buchheidt, Dieter  |m 1028287461:Buchheidt, Dieter  |d 60000  |d 61200  |e 60000PB1028287461  |e 61200PB1028287461  |k 0/60000/  |k 1/60000/61200/  |p 1  |x j 
999 |a KXP-PPN1571694617  |e 300490375X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"origin":[{"publisher":"Taylor & Francis Group ; Future Drugs ; Expert Reviews ; Informa Healthcare","dateIssuedKey":"2001","publisherPlace":"Abingdon ; London ; London ; London","dateIssuedDisp":"2001-"}],"language":["eng"],"id":{"eki":["355690462"],"zdb":["2090852-0"],"issn":["1744-8352"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Expert review of molecular diagnostics","title":"Expert review of molecular diagnostics"}],"part":{"extent":"8","year":"2017","issue":"6","volume":"17","text":"17(2017), 6, Seite 603-610","pages":"603-610"},"disp":"Evaluating the use of PCR for diagnosing invasive aspergillosisExpert review of molecular diagnostics","pubHistory":["1.2001 -"],"recId":"355690462","note":["Gesehen am 03.09.15"]}],"physDesc":[{"extent":"8 S."}],"person":[{"family":"Buchheidt","display":"Buchheidt, Dieter","given":"Dieter","role":"aut"},{"given":"Mark","display":"Reinwald, Mark","family":"Reinwald","role":"aut"},{"role":"aut","display":"Hofmann, Wolf-Karsten","family":"Hofmann","given":"Wolf-Karsten"},{"family":"Boch","display":"Boch, Tobias","given":"Tobias","role":"aut"},{"given":"Birgit","family":"Spiess","display":"Spiess, Birgit","role":"aut"}],"title":[{"title_sort":"Evaluating the use of PCR for diagnosing invasive aspergillosis","title":"Evaluating the use of PCR for diagnosing invasive aspergillosis"}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"10 May 2017"}],"language":["eng"],"id":{"doi":["10.1080/14737159.2017.1325735"],"eki":["1571694617"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1571694617","note":["Gesehen am 04.04.2018"],"name":{"displayForm":["Dieter Buchheidt, Mark Reinwald, Wolf-Karsten Hofmann, Tobias Boch, Birgit Spiess"]}} 
SRT |a BUCHHEIDTDEVALUATING1020